KIR Donor Selection: Feasibility in Identifying Better Donors

We previously reported that AML transplants using KIR B haplotype Better or Best (≥2 B activating gene loci ± Cen B/B) unrelated donors (URD) yield less relapse and better survival. In this prospective trial we evaluated 535 AML searches from 14 participating centers with centralized donor KIR genot...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Weisdorf, Daniel, Cooley, Sarah, Wang, Tao, Trachtenberg, Elizabeth, Haagenson, Michael D., Vierra-Green, Cynthia, Spellman, Stephen, Spahn, Ashley, Vogel, Jenny, Kobusingye, Hati, Fehninger, Todd, Woolfrey, Ann, Devine, Steven, Ross, Maureen, Waller, Edmund K., Sobecks, Ronald, Parham, Peter, Guethlein, Lisbeth A, GE Marsh, Steven, Miller, Jeffrey
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6310641/
https://ncbi.nlm.nih.gov/pubmed/30149149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.08.022
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars